The cancer challenge: the quest for a cure is only half the battle
BMS, cancer, end of life care, immuno-oncology, immunotherapy, Merck, Oncology, oncology drug pricing, patients
0 Comment
The cancer challenge is affecting more and more people worldwide, with 21 million cases expected by 2030.